Efavirenz Tablets are a medicine used in the treatment of HIV infection. They belong to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Here are the key details:

• Composition: Each tablet contains Efavirenz as the active ingredient, commonly in strengths such as 600 mg.

• Dosage Form: Oral tablets, usually taken once daily, preferably at bedtime, on an empty stomach.

• Mode of Action:

  • Efavirenz inhibits the reverse transcriptase enzyme of HIV, which is essential for viral replication.

  • By blocking this enzyme, it reduces the viral load in the body and helps maintain immune system function.

• Uses:

  • Treatment of HIV-1 infection in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART).

• Treatment Goal: To suppress HIV viral replication, maintain immune function, and slow disease progression.

• Side Effects:

  • Common: dizziness, drowsiness, headache, vivid dreams, nausea, rash.

  • Less common/serious: liver problems, severe skin reactions, psychiatric symptoms (anxiety, depression, suicidal thoughts), abnormal lipid levels.

• Precautions:

  • Should not be used alone; always in combination with other antiretrovirals.

  • Regular monitoring of liver function and viral load is recommended.

  • Can interact with many other medications due to effects on liver enzymes.

  • Not recommended during pregnancy unless benefits outweigh risks.

  • Patients should be advised to take it at bedtime to reduce CNS side effects.

👉 Efavirenz is effective in controlling HIV infection when used as part of a combination therapy, but careful monitoring is essential due to potential neurological and liver-related side effects.